Biotech

All Articles

Editas exploit Tip Cas9 licensing civil liberties for $57M

.Against the background of a Cas9 license battle that declines to perish, Editas Medicine is moneyin...

Ultragenyx modifies gene treatment dosing to dial up efficiency

.A minority of patients taking Ultragenyx Pharmaceutical's Wilson illness genetics treatment UX701 h...

Biopharma layoff price stabilizes in Q3: Fierce Biotech study

.As summer warm turns to cool down winds, wishes that this year will bring prevalent market alleviat...

J &amp J goes down phase 2 dengue applicant in newest shift from injections

.Johnson &amp Johnson's deprioritization of its own infectious condition pipe has professed another ...

Relay loses 10% of team after earlier layoffs in July

.Preciseness medicine biotech Relay Therapeutics is actually losing about 10% of its labor force in ...

Pentixapharm scores $22M IPO to advance radiopharma tests

.Pentixapharm has generated virtually twenty million euros ($ 22 million) from an IPO, with the Germ...

Lundbeck faucets Charles Stream for AI-enabled neuro medicine breakthrough

.Lundbeck has used Charles River Laboratories' artificial intelligence abilities to assist the inven...

Big pharma, biotech 'will not automatically be actually symbiotic' in artificial intelligence: S&ampP

.Significant Pharma is putting in intensely in artificial intelligence to slash growth timelines and...

I &amp I biotech Triveni raises $115M for preclinical antitoxins

.Triveni Biography has roped in $115 thousand in collection B funds to evolve preclinical antibody c...

IGM rotates coming from cancer cells to autoimmune, agitating C-suite

.IGM Biosciences ended last year laying off workers and improving its own cancer pipe. Currently, th...